Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Lowdell

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Blood|August 19, 2010
The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironmentAndrew J Steele, Archibald G Prentice, Kate Cwynarski, et al.
Current Stem Cell Reports|November 28, 2017
Autologous Cell Seeding in Tracheal Tissue EngineeringElizabeth F Maughan, Robert E Hynds, Toby J Proctor, et al.
Immunology|October 21, 2005
Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activityElena G Addison, Janet North, Ismail Bakhsh, et al.
Stem Cells Translational Medicine|February 14, 2017
Stem Cell-Based Tissue-Engineered Laryngeal ReplacementTahera Ansari, Peggy Lange, Aaron Southgate, et al.
Blood|October 25, 2003
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugsDylan T Jones, Elena Addison, Janet M North, et al.
Cytotherapy|July 18, 2016
Manufacture of GMP-compliant functional adenovirus-specific T-cell therapy for treatment of post-transplant infectious complicationsClaire Horlock, Amanda Skulte, Arindam Mitra, et al.
Cytotherapy|October 12, 2013
Regulation of advanced therapy medicinal products in Europe and the role of academiaKim F Pearce, Martin Hildebrandt, Hildegard Greinix, et al.
American Journal of Hematology|September 16, 2011
Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cellsEirini Katodritou, Evangelos Terpos, Janet North, et al.
Glycobiology|September 27, 2006
Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapyHeide Kogelberg, Berend Tolner, Surinder K Sharma, et al.
Cancer Research|March 23, 2005
Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptideAlexandra J Marks, Margaret S Cooper, Robert J Anderson, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Blood|August 19, 2010
The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironmentAndrew J Steele, Archibald G Prentice, Kate Cwynarski, et al.
Current Stem Cell Reports|November 28, 2017
Autologous Cell Seeding in Tracheal Tissue EngineeringElizabeth F Maughan, Robert E Hynds, Toby J Proctor, et al.
Immunology|October 21, 2005
Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activityElena G Addison, Janet North, Ismail Bakhsh, et al.
Stem Cells Translational Medicine|February 14, 2017
Stem Cell-Based Tissue-Engineered Laryngeal ReplacementTahera Ansari, Peggy Lange, Aaron Southgate, et al.
Blood|October 25, 2003
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugsDylan T Jones, Elena Addison, Janet M North, et al.
Cytotherapy|July 18, 2016
Manufacture of GMP-compliant functional adenovirus-specific T-cell therapy for treatment of post-transplant infectious complicationsClaire Horlock, Amanda Skulte, Arindam Mitra, et al.
Cytotherapy|October 12, 2013
Regulation of advanced therapy medicinal products in Europe and the role of academiaKim F Pearce, Martin Hildebrandt, Hildegard Greinix, et al.
American Journal of Hematology|September 16, 2011
Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cellsEirini Katodritou, Evangelos Terpos, Janet North, et al.
Glycobiology|September 27, 2006
Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapyHeide Kogelberg, Berend Tolner, Surinder K Sharma, et al.
Cancer Research|March 23, 2005
Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptideAlexandra J Marks, Margaret S Cooper, Robert J Anderson, et al.
Pageof 8